Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________to__________ Commission File Number: 001-40154 Oscar Health, Inc. (Exact name of registrant as specified in its charter) Delaware 46-1315 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________to__________ Commission File Number: 001-40154 ____________________________________________________________ Oscar Health, Inc. (Exact name of ...

Oscar Health, Inc. Fourth Quarter and Full Year 2022 Earnings Presentation HIOSCAR.COM This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained herein are forward-looking statements. These statements include, but are not limited to, statements about our financial outlook and estimates, including direct and assumed policy premiums, medical loss ratio, InsuranceCo administ ...

Oscar Health, Inc. (NYSE:OSCR) Q4 2022 Earnings Conference Call February 9, 2023 5:00 PM ET Company Participants Cornelia Miller – Vice President of Corporate Development and Investor Relations Mario Schlosser – Co-Founder and Chief Executive Officer Sid Sankaran – Chief Financial Officer Conference Call Participants Michael Ha – Morgan Stanley Jonathan Yong – Credit Suisse Gary Taylor – Cowen Kevin Fischbeck – Bank of America Josh Raskin – Nephron Research Nathan Rich – Goldman Sachs Stephen Baxter – Wells ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________to__________ For the quarterly period ended September 30, 2022 Commission File Number: 001-40154 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ____________________________________________________________ Oscar Health, Inc. (Exact ...

Oscar Health, Inc. (NYSE:OSCR) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Cornelia Miller - Vice President, Corporate Development and Investor Relations Mario Schlosser - Co-Founder and Chief Executive Officer Scott Blackley - Chief Financial Officer Sid Sankaran - Interim Chief Financial Officer Conference Call Participants Connor Massari - Morgan Stanley Stephen Baxter - Wells Fargo Nathan Rich - Goldman Sachs Josh Raskin - Nephron Research Operator Good afternoon. M ...

Oscar Health, Inc. (NYSE:OSCR) Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Cornelia Miller - Vice President of Corporate Development & Investor Relations Mario Schlosser - Co-Founder & Chief Executive Officer Scott Blackley - Chief Financial Officer Conference Call Participants Michael Hall - Morgan Stanley Stephen Baxter - Wells Fargo Securities Jonathan Yong - Credit Suisse Kevin Fischbeck - Bank of America Josh Raskin - Nephron Research Lindsay Golub - Goldman Sachs O ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________to__________ Commission File Number: 001-40154 ____________________________________________________________ Oscar Health, Inc. (Exact name of registrant as specified in its charter) | Delaware | ____________________________________________________________ | 46-1315570 | | -- ...

Oscar Health, Inc. Second Quarter 2022 Earnings Presentation August 11, 2022 HIOSCAR.COM Safe Harbor Statement and Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained herein are forward-looking statements. These statements include, but are not limited to, statements about our financial outlook and estimates, including direct and assumed po ...

Oscar Health, Inc. First Quarter 2022 Earnings Presentation May 10, 2022 HIOSCAR.COM Safe Harbor Statement and Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained herein are forward-looking statements. These statements include, but are not limited to, statements about our financial outlook and estimates, including direct and assumed policy ...